22157.jpg
POC Diagnostics Industry 2019-2024, 7th Edition - A Deep Look Into the Shift from Curative Medicine to Predictive, Personalized, and Preemptive Medicine
April 29, 2020 05:08 ET | Research and Markets
Dublin, April 29, 2020 (GLOBE NEWSWIRE) -- The "The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine...
MedMira Corp Logo no tagline.png
MedMira Announces Notification Submission to US FDA Emergency Use Authorization
April 23, 2020 07:00 ET | MedMira Inc.
HALIFAX, Nova Scotia, April 23, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), announced today that it had submitted the notification for the Emergency Use Authorization application...
MedMira Corp Logo no tagline.png
MedMira gibt ein Update zur Entwicklung eines Point-of-Care-Antikörpertests bekannt
April 20, 2020 10:32 ET | MedMira Inc.
HALIFAX, Nova Scotia, April 20, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), hat heute bekanntgegeben, dass es die Entwicklung einer serologischen Point-of-Care-(POC)-Testlösung mit...
MedMira Corp Logo no tagline.png
MedMira annonce une mise à jour concernant le développement de son test de détection d'anticorps sur le lieu de soins
April 20, 2020 10:32 ET | MedMira Inc.
HALIFAX, Nouvelle-Écosse, 20 avr. 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV : MIR) a annoncé aujourd'hui avoir achevé le développement de la solution de test sérologique sur le lieu...
REVEALCOVID-19 Total Antibody Test
MedMira Announces Update on Development of Point-of-Care Antibody Test
April 17, 2020 11:01 ET | MedMira Inc.
HALIFAX, Nova Scotia, April 17, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), announced today that it has completed the development of the serological Point-of-Care (POC) testing...
REVEALCOVID-19 Total Antibody Test
MedMira Announces Update on Development of Point-of-Care Antibody Test
April 15, 2020 20:00 ET | MedMira Inc.
HALIFAX, Nova Scotia, April 15, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), announced today that it has completed the development of the serological Point-of-Care (POC) testing...
MedMira Corp Logo no tagline.png
MedMira Reports Second Quarter Results FY2020
March 31, 2020 18:00 ET | MedMira Inc.
HALIFAX, Nova Scotia, March 31, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended January 31, 2020.  Profit and Loss...
MedMira Corp Logo no tagline.png
MedMira Reports First Quarter Results FY2020
December 30, 2019 19:00 ET | MedMira Inc.
HALIFAX, Nova Scotia, Dec. 30, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2019.  Profit and Loss...
22157.jpg
Global STD Diagnostics Markets to 2024 - Implementation of National Screening Programs Spur Industry Growth
December 04, 2019 07:43 ET | Research and Markets
Dublin, Dec. 04, 2019 (GLOBE NEWSWIRE) -- The "STD Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.The major...
MedMira Corp Logo no tagline.png
MedMira Reports 2019 Fourth Quarter and Year End Financial Results
November 28, 2019 20:00 ET | MedMira Inc.
HALIFAX, Nova Scotia, Nov. 28, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the financial year ended July 31, 2019.  Profit and Loss...